Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.86 USD | -0.46% | +4.60% | +26.34% |
21/06 | BofA Securities Adjusts PTC Therapeutics Price Target to $32 From $25, Maintains Underperform Rating | MT |
20/06 | Sector Update: Health Care Stocks Lean Lower Pre-Bell Thursday | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+26.34% | 268.59Cr | |
+16.32% | 12TCr | |
+19.37% | 12TCr | |
+21.22% | 2.66TCr | |
-23.77% | 1.99TCr | |
-17.47% | 1.63TCr | |
-45.95% | 1.55TCr | |
-18.09% | 1.55TCr | |
+64.27% | 1.48TCr | |
+2.14% | 1.37TCr |
- Stock Market
- Equities
- PTCT Stock
- News PTC Therapeutics, Inc.
- PTC Therapeutics Reports Favorable Interim Results in Huntington's Disease Study; US FDA Lifts Clinical Hold